What to Know About Leqembi, the Alzheimer’s Drug Approved by the FDA - The New York Times
https://www.nytimes.com/2023/07/06/health/leqembi-alzheimers-drug.html
Medicare will cover much of the cost for patients in the early stages of the disease, but Leqembi has safety risks and can only modestly slow cognitive decline.
https://www.nytimes.com/2023/07/06/health/leqembi-alzheimers-drug.html
Medicare will cover much of the cost for patients in the early stages of the disease, but Leqembi has safety risks and can only modestly slow cognitive decline.